Abbott Sues Watson Over Drug Ads

How can you keep pace with an accelerating marketing ecosystem? Join us at Brandweek Sept. 12–16 in Miami alongside leading CMOs, founders and change makers from GatoradeMarriottAlo YogaCampbell'sUncommon James and more. Book now.


ABBOTT PARK, Ill. — Abbott Laboratories filed a lawsuit against Watson Pharmaceuticals Inc. in Chicago, seeking a federal court injunction to immediately stop Watson’s advertising and trade practices regarding Abbott’s prescription thyroid drug Synthroid.

Abbott (ABT) said Tuesday it also asked the court to order Watson (WPI) to undertake an advertising campaign to correct “the deliberate misinformation it has created within the medical community.”

AW+

INDEPENDENCE DAY SALE

Subscribe today!

APPLY PROMO CODE "JULY20" AT CHECK OUT FOR 20% OFF

View Subscription Options

Already a member? Sign in